Todd C Brady, Director, President and CEO, on June 03, 2026, executed a purchase for 250,000 shares in Aldeyra Therapeutics (ALDX) for $418,450. Following the Form 4 filing with the SEC, Brady has control over a total of 1,721,298 common shares of the company, with 1,721,298 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1341235/000119312526259637/xslF345X05/ownership.xml
James C Katzman, Director, on June 04, 2026, executed a purchase for 25,000 shares in Applied Aerospace & Defense (AADX) for $500,000. Following the Form 4 filing with the SEC, Katzman has control over a total of 29,250 common shares of the company, with 29,250 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2118195/000119312526257841/xslF345X05/ownership.xml
Larissa Schwartz, Chief Legal Officer and Corporate Secretary, on June 02, 2026, sold 24,971 shares in Okta (OKTA) for $3,349,398. Following the Form 4 filing with the SEC, Schwartz has control over a total of 23,477 Class A common shares of the company, with 23,477 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1660134/000196812526000009/xslF345X05/wk-form4_1780609640.xml
Ravi Gupta, 10% Owner, Director, on June 02, 2026, sold 181,000 shares in Maplebear (CART) for $7,513,871. Following the Form 4 filing with the SEC, Gupta has control over a total of 28,770,411 common shares of the company, with 15,006 shares held directly and 28,755,405 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1579091/000198846026000004/xslF345X05/form4.xml